Helius Medical Technologies Inc. Announces Upcoming Participation and Presentation at the Cowen and Company 37th Annual Healthcare Conference
(firmenpresse) - NEWTOWN, PENNSYLVANIA -- (Marketwired) -- 02/22/17 -- Helius Medical Technologies, Inc. (TSX: HSM)(TSX: HSM.S)(OTCQB: HSDT) ("Helius" or the "Company") announced its upcoming presentation at the Cowen and Company 37th Annual Healthcare Conference, March 6-8, 2017, at the Boston Marriott Copley Place, Boston. President and CEO, Phillippe Deschamps will be presenting at 3:20pm EST on March 6, 2017.
The presentation will be webcast, and a replay will be accessible for 90-days following the event, at the following link: .
Institutional investors may schedule one-on-one meetings by contacting Cowen Institutional Sales or by contacting Helius directly.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a medical technology company focused on neurological wellness. Helius seeks to develop, license and acquire unique and non-invasive platform technologies that amplify the brain''s ability to heal itself. For more information, please visit .
The Toronto Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Cautionary Disclaimer Statement:
Certain statements in this news release are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws ("forward-looking statements").
All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. Such forward-looking statements include, among others, statements regarding ongoing or planned clinical research, expected future development timelines, regulatory approvals, business initiatives and objectives and use of proceeds from financings or other business initiatives.
Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions.
There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company''s expectations include the failure of the Company to achieve its business objectives and other risks detailed from time to time in the filings made by the Company with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking statement. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Risks and uncertainties about the Company''s business are more fully discussed in the Company''s disclosure materials, including the short form prospectus filed in connection with the Offering, its Annual Report on Form 10-K filed with the United States Securities and Exchange Commission and the Canadian securities regulators and which can be obtained from either at or .
The forward-looking statements contained in this news release are made as of the date of this news release and the Company assumes no obligation to update any forward-looking statement or to update the reasons why actual results could differ from such statements except to the extent required by law.
Contacts:
Helius Medical Technologies
Corporate and Investor Contact
Brian Bapty
604-652-3950
Media Contact
Becky Kern
914-772-2310
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.02.2017 - 08:00 Uhr
Sprache: Deutsch
News-ID 1488307
Anzahl Zeichen: 2642
contact information:
Contact person:
Town:
NEWTOWN, PENNSYLVANIA
Phone:
Kategorie:
Medical Devices
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 278 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Helius Medical Technologies Inc. Announces Upcoming Participation and Presentation at the Cowen and Company 37th Annual Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Helius Medical Technologies, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
